| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a888a536389af4a49ebdc2c36de65848 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2019-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d37ed63c609af71fd09cad710630a736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_478d811496830a62b2fbb89a4eee8022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b25c854a509f99e8192146d92f35b84f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14391d6c474820a41aa10ffba4e70c42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3de2fda3c2859b4e2332540e59138e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dce9fc64f2a3dd14e58a21881ff584c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09cfc7e6913a253271ed4389a3bdc4f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6980082206ac314df356e56bf222035e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8be4f9a1ab5bcd0ee27579c677fe5e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5571bd4e8493a98177c1a098d03c6ade |
| publicationDate |
2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11047866-B2 |
| titleOfInvention |
IGFBP7 for diagnosing diastolic dysfunction |
| abstract |
Presented is a method for diagnosing and/or grading diastolic dysfunction or at least one structural or functional abnormality associated with diastolic dysfunction. The method involves measuring the level of IGFBP7 (Insulin like growth factor binding protein 7) and, optionally, the level of at least one further marker in a patient suffering from heart failure, and comparing the level to a reference level. Further envisaged is a method of monitoring diastolic function in a patient suffering from heart failure. Also described are kits and devices adapted to carry out the method. |
| priorityDate |
2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |